-transparent.png){kind=logo}
A phase II study of cis-diamminedichloroplatinum (CDDP, 80 mg/m2, every 3 weeks) was performed in patients with non-small cell lung cancer (NSCLC). The overall response rate to CDDP was 14% (6/42). In patients without prior chemotherapy, the response rate was 20% (2/10), and in patients with prior chemotherapy, the response rate was 13% (4/31). The major side effect was gastrointestinal toxicity. It was concluded that CDDP at a dose of 80 mg/m2 every 3 weeks is effective against NSCLC.
Related Publications
J Fujita, and
N Saijo, and
K Eguchi, and
E Shimizu, and
T Shinkai, and
K Tominaga, and
Y Sasaki, and
H Futami, and
M Sakurai, and
A Hoshi
January 1990,
Cancer chemotherapy and pharmacology,
J Fujita, and
N Saijo, and
K Eguchi, and
E Shimizu, and
T Shinkai, and
K Tominaga, and
Y Sasaki, and
H Futami, and
M Sakurai, and
A Hoshi
March 1985,
Gan to kagaku ryoho. Cancer & chemotherapy,
J Fujita, and
N Saijo, and
K Eguchi, and
E Shimizu, and
T Shinkai, and
K Tominaga, and
Y Sasaki, and
H Futami, and
M Sakurai, and
A Hoshi
November 1976,
Cancer treatment reports,
J Fujita, and
N Saijo, and
K Eguchi, and
E Shimizu, and
T Shinkai, and
K Tominaga, and
Y Sasaki, and
H Futami, and
M Sakurai, and
A Hoshi
March 1982,
Gan to kagaku ryoho. Cancer & chemotherapy,
J Fujita, and
N Saijo, and
K Eguchi, and
E Shimizu, and
T Shinkai, and
K Tominaga, and
Y Sasaki, and
H Futami, and
M Sakurai, and
A Hoshi
April 1983,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J Fujita, and
N Saijo, and
K Eguchi, and
E Shimizu, and
T Shinkai, and
K Tominaga, and
Y Sasaki, and
H Futami, and
M Sakurai, and
A Hoshi
April 1994,
International journal of cancer,
J Fujita, and
N Saijo, and
K Eguchi, and
E Shimizu, and
T Shinkai, and
K Tominaga, and
Y Sasaki, and
H Futami, and
M Sakurai, and
A Hoshi
June 1986,
Japanese journal of clinical oncology,
J Fujita, and
N Saijo, and
K Eguchi, and
E Shimizu, and
T Shinkai, and
K Tominaga, and
Y Sasaki, and
H Futami, and
M Sakurai, and
A Hoshi
January 1979,
Cancer treatment reports,
J Fujita, and
N Saijo, and
K Eguchi, and
E Shimizu, and
T Shinkai, and
K Tominaga, and
Y Sasaki, and
H Futami, and
M Sakurai, and
A Hoshi
June 1986,
Japanese journal of clinical oncology,
J Fujita, and
N Saijo, and
K Eguchi, and
E Shimizu, and
T Shinkai, and
K Tominaga, and
Y Sasaki, and
H Futami, and
M Sakurai, and
A Hoshi
October 2010,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
